The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A phase I study of safety and immunogenicity of survivin long peptide vaccine (SurVaxM) in patients (pts) with metastatic neuroendocrine tumors (NETs).

Medhavi  Gupta

No Relationships to Disclose

Robert Alan  Fenstermaker

Stock and Other Ownership Interests  - MimiVax

Patents, Royalties, Other Intellectual Property - I hold several patents for technology related to cancer vaccines, antibodies and related cellular therapies

Jing-Xin  Qiu

Honoraria - Merck

Consulting or Advisory Role - Merck

Speakers' Bureau - Merck

Renuka V.  Iyer

Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Lexicon; Merck; Novartis; QED therapeutics; Sun pharma

Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)